Valneva SE (VALN) EPS (Weighted Average and Diluted) (2021 - 2023)

Valneva SE's (VALN) quarterly EPS (Weighted Average and Diluted) came in at -$127492.3 in Q1 2023, down 22.21% year-on-year from -$163896.6 in Q1 2022, and down 262.45% quarter-over-quarter from $78480.4 in Q3 2022.

Valneva SE (VALN) EPS (Weighted Average and Diluted) (2021 - 2023) Analysis & Trends

Valneva SE has disclosed EPS (Weighted Average and Diluted) across 3 years of filings, most recently posting -$127492.3 for Q1 2023.

  • EPS (Weighted Average and Diluted) for Q1 2023 came in at -$127492.3, down 22.21% year-over-year; the trailing twelve-month figure through Mar 2023 was -$127492.3 (down 22.21% YoY), and the FY2025 annual result was -$0.79, down 825.92% from the prior year.
  • EPS (Weighted Average and Diluted) came in at -$127492.3 for Q1 2023 at Valneva SE, down from $78480.4 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $78480.4 in Q3 2022 to a low of -$127492.3 in Q1 2023.
  • The 3-year median for EPS (Weighted Average and Diluted) is -$83550.3 (2021), against an average of -$54028.1.
  • Across the five-year window, EPS (Weighted Average and Diluted) jumped 225.01% in 2022 and fell 22.21% in 2023, its largest moves.
  • Valneva SE's EPS (Weighted Average and Diluted) stood at -$62779.7 in 2021, then surged by 225.01% to $78480.4 in 2022, then tumbled by 262.45% to -$127492.3 in 2023.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$127492.3 (Q1 2023), $78480.4 (Q3 2022), and -$104320.8 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 0.68
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 3.06
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 3,086.42
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 0.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 0.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 4.02
9 Abivax 94.26 Bn 94.26 Bn - -0.61
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 -127,492.31
Sep 30, 2022 78,480.43
Mar 31, 2022 -104,320.83
Sep 30, 2021 -62,779.68